Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-092797
Filing Date
2020-08-10
Accepted
2020-08-10 16:41:52
Documents
66
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q nwbo-20200630x10q.htm   iXBRL 10-Q 2193059
2 EXHIBIT 31.1 nwbo-20200630xex31d1.htm EX-31.1 15571
3 EXHIBIT 32.1 nwbo-20200630xex32d1.htm EX-32.1 10328
  Complete submission text file 0001104659-20-092797.txt   9606071

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA nwbo-20200630.xsd EX-101.SCH 58466
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nwbo-20200630_cal.xml EX-101.CAL 44809
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nwbo-20200630_def.xml EX-101.DEF 222610
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE nwbo-20200630_lab.xml EX-101.LAB 420980
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nwbo-20200630_pre.xml EX-101.PRE 385511
9 EXTRACTED XBRL INSTANCE DOCUMENT nwbo-20200630x10q_htm.xml XML 2306741
Mailing Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814
Business Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814 (240) 497-9024
NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)

EIN.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35737 | Film No.: 201089950
SIC: 2834 Pharmaceutical Preparations